71566-39-7
sodium bis[3-[[1-(4-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]-4-hydroxy-N-methylbenzenesulphonamidato(2-)]cobaltate(1-)
CAS: 71566-39-7
Molecular Formula: C34H30Cl2CoN10NaO8S2-
71566-39-7 - Names and Identifiers
71566-39-7 - Physico-chemical Properties
| Molecular Formula | C34H30Cl2CoN10NaO8S2- |
| Molar Mass | 923.62317 |
71566-39-7 - Introduction
Sodium bis[3-[[1-(4-chlorophenyl)-4, 5-Dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl] azo]-4-hydroxy-n-methylbenzenesulfonamide (2-)]cobaltate(1-) is a complex. The following is a detailed description of its nature, use, preparation and safety information:
Nature:
-chemical formula: C29H25ClCoN9NaO5S2
-Molecular weight: 807.11g/mol
-Appearance: dark red solid
-Solubility: soluble in water
Use:
- Sodium bis[3-[[1-(4-chlorophenyl)-4, 5-Dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl] azo]-4-hydroxy-n-methylbenzenesulfonamide (2-)]cobaltate(1-) in the chemical industry as a dye, catalyst, in organic synthesis can be used for catalytic coupling reaction.
Preparation Method:
- Sodium bis[3-[[1-(4-chlorophenyl)-4, 5-Dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl] azo]-4-hydroxy-n-methylbenzenesulfonamide (2-)]cobaltate(1-) can be generated under reaction conditions by adding the substrate to a solution of a cobalt salt and a ligand.
Safety Information:
-The specific safety evaluation of this compound requires further study. However, general laboratory safety practices, such as wearing protective gloves, eye protection glasses, etc., should be followed during handling and use. At the same time, avoid inhaling dust or solution and avoid direct skin contact.
Nature:
-chemical formula: C29H25ClCoN9NaO5S2
-Molecular weight: 807.11g/mol
-Appearance: dark red solid
-Solubility: soluble in water
Use:
- Sodium bis[3-[[1-(4-chlorophenyl)-4, 5-Dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl] azo]-4-hydroxy-n-methylbenzenesulfonamide (2-)]cobaltate(1-) in the chemical industry as a dye, catalyst, in organic synthesis can be used for catalytic coupling reaction.
Preparation Method:
- Sodium bis[3-[[1-(4-chlorophenyl)-4, 5-Dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl] azo]-4-hydroxy-n-methylbenzenesulfonamide (2-)]cobaltate(1-) can be generated under reaction conditions by adding the substrate to a solution of a cobalt salt and a ligand.
Safety Information:
-The specific safety evaluation of this compound requires further study. However, general laboratory safety practices, such as wearing protective gloves, eye protection glasses, etc., should be followed during handling and use. At the same time, avoid inhaling dust or solution and avoid direct skin contact.
Last Update：2024-04-10 22:29:15
Supplier List
View History
71566-39-7
5-氨基-3-氰基-1-(2,6-二氯-4-三氟甲基苯基)吡唑
Ezetimibe Impurity 14
2-DEOXY-2-PHTHALIMIDO-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL FLUORIDE
嘧啶-4-乙酸乙酯
1H-Indole-3-ethanamine, 5-methoxy-7-nitro-, hydrochloride (1:1)
茵芋苷
tetrapotassium sodium bis[6-[(5-chloro-2,6-difluoropyrimidin-4-yl)amino]-4-hydroxy-3-[(2-hydroxy-5-nitro-3-sulphophenyl)azo]naphthalene-2-sulphonato(4-)]cobaltate(5-)
AKOS BAR-0239
MYO-肌醇六乙酸酯
5-氨基-3-氰基-1-(2,6-二氯-4-三氟甲基苯基)吡唑
Ezetimibe Impurity 14
2-DEOXY-2-PHTHALIMIDO-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL FLUORIDE
嘧啶-4-乙酸乙酯
1H-Indole-3-ethanamine, 5-methoxy-7-nitro-, hydrochloride (1:1)
茵芋苷
tetrapotassium sodium bis[6-[(5-chloro-2,6-difluoropyrimidin-4-yl)amino]-4-hydroxy-3-[(2-hydroxy-5-nitro-3-sulphophenyl)azo]naphthalene-2-sulphonato(4-)]cobaltate(5-)
AKOS BAR-0239
MYO-肌醇六乙酸酯